(Reuters) - Johnson & Johnson and its DePuy Orthopaedics unit have agreed to pay $120 million to resolve deceptive marketing claims by several U.S. states over the company's metal-on-metal hip implants.
Attorneys general of 46 U.S. states announced the settlement agreement in statements on Tuesday. They alleged DePuy engaged in unfair and deceptive practices in its promotion of the ASR XL and Pinnacle Ultamet hip implant devices.
J&J did not immediately respond to a request for comment.
(Reporting by Tina Bellon in New York; Editing by Chizu Nomiyama)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 146.5 USD | +0.54% | +0.22% | 353B | ||
